Lindbrook Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-546
| Closed | -$22.3K | – | 2941 |
|
|
2024
Q2 | $22.3K | Hold |
546
| – | – | ﹤0.01% | 1185 |
|
|
2024
Q1 | $23.1K | Hold |
546
| – | – | ﹤0.01% | 1136 |
|
|
2023
Q4 | $23.2K | Buy |
546
+456
| +507% | +$19.3K | ﹤0.01% | 1101 |
|
|
2023
Q3 | $1.97K | Buy |
90
+15
| +20% | +$327 | ﹤0.01% | 2135 |
|
|
2023
Q2 | $2.38K | Buy |
+75
| New | +$2.38K | ﹤0.01% | 2085 |
|
|
2022
Q1 | – | Sell |
-130
| Closed | -$4K | – | 2653 |
|
|
2021
Q4 | $4K | Buy |
130
+80
| +160% | +$2.46K | ﹤0.01% | 1620 |
|
|
2021
Q3 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 1816 |
|